Intra-Cellular Therapies registers JNJ-99245354 (ITI-1284) in generalized anxiety disorder
This study was first posted on ClinicalTrials.gov on October 2, 2026. The trial plans to enroll 705 participants and has a planned start date of September 30, 2026, with a primary completion date of September 20, 2030.
Primary source
ClinicalTrials.gov registry record, October 2, 2026
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
Machine-summarized from the source above; not independently reported. How we use automation